HBIO 2.16 (+5.37%)
US4169061052• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. HBIO

Harvard Bioscience (HBIO) Competitor Comparison

We are evaluating the key criteria listed to compare Harvard Bioscience (HBIO) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

34 / 44

Gross Profits

29 / 40

Total Revenue

31 / 43

EBITDA

25 / 44

Free Cashflow

26 / 44

Quick Ratio

41 / 44

Earnings per Share

24 / 44

Dividend yield

0 / 13

Total Cash

40 / 44

Performance 3 years

34 / 44

Performance 5 years

20 / 44

Performance 10 years

32 / 44

Linearity 3 years

28 / 44

Linearity 5 years

9 / 44

Linearity 10 years

11 / 44

Total Rank

36 / 44

Dividend Rank

42 / 44

Valuation Rank

30 / 44

Piotroski Rank

38 / 44

Muliplier Rank

41 / 44

Earnings per Share - HBIO ranking 24 / 44

These are the competitors of Harvard Bioscience in the industry Medical Instruments & Supplies ranked by earnings per share
1. ResMed RMD
7.53
2. Atrion ATRI
7.13
3. West Pharmaceutical Services WST
6.73
4. Intuitive Surgical ISRG
6.24
5. Steris STE
6.06
6. Becton, Dickinson BDX
5.93
7. Teleflex TFX
5.05
8. Utah Medical Products UTMD
4.32
9. Hologic HOLX
3.32
10. Haemonetics HAE
2.26
11. Alcon ALC
2.22
12. Ansell PD1.F
2.2
13. Merit Medical Systems MMSI
2.07
14. LeMaitre Vascular LMAT
1.88
15. Cooper Companies COO
1.8
16. Pro-Dex PDEX
1.58
17. Masimo MASI
1.45
18. Staar Surgical STAA
0.41
19. OraSure Technologies OSUR
0.15
20. Repligen RGEN
-0.03
21. Nephros NEPH
-0.12
22. KORU Medical Systems KRMD
-0.26
23. Warby Parker WRBY
-0.27
24. Harvard Bioscience HBIO
-0.27
25. Baxter BAX
-0.3
26. NexGel NXGL
-0.63
27. Ekso Bionics Holdings EKSO
-0.79
28. Pulse Biosciences PLSE
-0.82
29. AtriCure ATRC
-0.83
30. Femasys FEMY
-0.85
31. Bausch & Lomb BLCO
-1.04
32. Microbot Medical MBOT
-1.05
33. Akoya Biosciences AKYA
-1.17
34. NovoCure NVCR
-1.37
35. BioLife Solutions BLFS
-1.44
36. electroCore ECOR
-2.05
37. Dentsply Sirona XRAY
-2.1
38. ICU Medical ICUI
-2.9
39. Glaukos GKOS
-2.93
40. Predictive Oncology POAI
-3.66
41. NeuroMetrix NURO
-4.38
42. iRhythm Technologies IRTC
-4.72
43. AngioDynamics ANGO
-6.05
44. Envista Holdings NVST
-7.45
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.